Koninklijke Philips (PHG) Non-Current Deffered Revenue (2017 - 2026)
Koninklijke Philips (PHG) posted quarterly Non-Current Deffered Revenue of $539.3 million for Q2 2026, up 15.65% year-over-year from $466.4 million in Q2 2025, and up 5.18% quarter-over-quarter from $512.8 million in Q1 2026.
Koninklijke Philips (PHG) Non-Current Deffered Revenue (2017 - 2026) Analysis & Trends
Koninklijke Philips' Non-Current Deffered Revenue history runs 10 years deep, the most recent figure standing at $539.3 million for Q2 2026.
- In Q2 2026, Non-Current Deffered Revenue rose 15.65% year-over-year to $539.3 million; the TTM figure through Jun 2026 stood at $539.3 million (up 15.65% YoY), while the FY2025 annual figure was $533.1 million, up 15.76% from the prior year.
- Non-Current Deffered Revenue for Q2 2026 stood at $539.3 million, up from $512.8 million in the prior quarter.
- The five-year high for Non-Current Deffered Revenue was $539.3 million in Q2 2026, with the low at $433.4 million in Q1 2025.
- The 5-year median for Non-Current Deffered Revenue is $508.7 million (2023), against an average of $500.2 million.
- The sharpest annual moves came in 2024 and 2026: Non-Current Deffered Revenue decreased 10.71% in 2024, then rose 18.32% in 2026.
- Koninklijke Philips' Non-Current Deffered Revenue stood at $525.4 million in 2022, then dropped by 3.96% to $504.6 million in 2023, then declined by 8.73% to $460.6 million in 2024, then grew by 15.76% to $533.1 million in 2025, then grew by 1.16% to $539.3 million in 2026.
- Business Quant data shows PHG's Non-Current Deffered Revenue at $539.3 million in Q2 2026, $512.8 million in Q1 2026, and $533.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 539.34 Mn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | - |
| 10 | Zimmer Biomet Holdings | 19.38 Bn | 18.97 Bn | 1.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 539.34 Mn |
| Mar 31, 2026 | 512.79 Mn |
| Dec 31, 2025 | 533.13 Mn |
| Sep 30, 2025 | 485.16 Mn |
| Jun 30, 2025 | 466.37 Mn |
| Mar 31, 2025 | 433.38 Mn |
| Dec 31, 2024 | 460.56 Mn |
| Jun 30, 2024 | 480.29 Mn |
| Dec 31, 2023 | 504.62 Mn |
| Jun 30, 2023 | 537.93 Mn |
| Dec 31, 2022 | 525.43 Mn |
| Jun 30, 2022 | 522.86 Mn |
| Dec 31, 2021 | 510.21 Mn |
| Jun 30, 2021 | 507.00 Mn |
| Dec 31, 2020 | 480.49 Mn |
| Jun 30, 2020 | 395.42 Mn |
| Dec 31, 2019 | 385.20 Mn |
| Jun 30, 2019 | 326.98 Mn |
| Dec 31, 2018 | 257.96 Mn |
| Jun 30, 2018 | 263.75 Mn |